Most-Read Articles during February 2018 -- updated monthly

Most-read rankings are recalculated at the beginning of the month and are based on full-text and pdf views.

  1. Research:
    • G Azizi,
    • J M Keller,
    • M Lewis,
    • K Piper,
    • D Puett,
    • K M Rivenbark,
    • and C D Malchoff
    Association of Hashimoto's thyroiditis with thyroid cancer Endocr Relat Cancer 21 (6) 845-852, doi:10.1530/ERC-14-0258 first published on 12 September 2014
    OPEN ACCESS ARTICLE
  2. Review:
    • Paolo Vigneri,
    • Francesco Frasca,
    • Laura Sciacca,
    • Giuseppe Pandini,
    • and Riccardo Vigneri
    Diabetes and cancer Endocr Relat Cancer 16 (4) 1103-1123, doi:10.1677/ERC-09-0087 first published on 20 July 2009
  3. Reviews:
    • R Malaguarnera,
    • V Vella,
    • R Vigneri,
    • and F Frasca
    p53 family proteins in thyroid cancer Endocr Relat Cancer 14 (1) 43-60, doi:10.1677/erc.1.01223
  4. Regular papers:
    • Urbain Weyemi,
    • Bernard Caillou,
    • Monique Talbot,
    • Rabii Ameziane-El-Hassani,
    • Ludovic Lacroix,
    • Odile Lagent-Chevallier,
    • Abir Al Ghuzlan,
    • Dirk Roos,
    • Jean-Michel Bidart,
    • Alain Virion,
    • Martin Schlumberger,
    • and Corinne Dupuy
    Intracellular expression of reactive oxygen species-generating NADPH oxidase NOX4 in normal and cancer thyroid tissues Endocr Relat Cancer 17 (1) 27-37, doi:10.1677/ERC-09-0175 first published on 24 September 2009
  5. Review:
    • Marion T Weigel and
    • Mitch Dowsett
    Current and emerging biomarkers in breast cancer: prognosis and prediction Endocr Relat Cancer 17 (4) R245-R262, doi:10.1677/ERC-10-0136 first published on 20 July 2010
  6. Review:
    • M M Muresan,
    • P Olivier,
    • J Leclère,
    • F Sirveaux,
    • L Brunaud,
    • M Klein,
    • R Zarnegar,
    • and G Weryha
    Bone metastases from differentiated thyroid carcinoma Endocr Relat Cancer 15 (1) 37-49, doi:10.1677/ERC-07-0229
  7. Reviews:
    • Suman Rice and
    • Saffron A Whitehead
    Phytoestrogens and breast cancer –promoters or protectors? Endocr Relat Cancer 13 (4) 995-1015, doi:10.1677/erc.1.01159
  8. Review:
    • Avaniyapuram Kannan Murugan,
    • Arasambattu Kannan Munirajan,
    • and Ali S Alzahrani
    Long noncoding RNAs: emerging players in thyroid cancer pathogenesis Endocr Relat Cancer 25 (2) R59-R82, doi:10.1530/ERC-17-0188 first published on 16 November 2017
  9. Thematic Review:
    • Priscilla Cukier,
    • Fernando C Santini,
    • Mariana Scaranti,
    • and Ana O Hoff
    Endocrine side effects of cancer immunotherapy Endocr Relat Cancer 24 (12) T331-T347, doi:10.1530/ERC-17-0358 first published on 12 October 2017
  10. Research:
    • Helen C Miller,
    • Adam E Frampton,
    • Anna Malczewska,
    • Silvia Ottaviani,
    • Euan A Stronach,
    • Rashpal Flora,
    • Daniel Kaemmerer,
    • Gert Schwach,
    • Roswitha Pfragner,
    • Omar Faiz,
    • Beata Kos-Kudła,
    • George B Hanna,
    • Justin Stebbing,
    • Leandro Castellano,
    • and Andrea Frilling
    MicroRNAs associated with small bowel neuroendocrine tumours and their metastases Endocr Relat Cancer 23 (9) 711-726, doi:10.1530/ERC-16-0044 first published on 27 June 2016
  11. Conference Papers:
    • L A Bazley and
    • W J Gullick
    The epidermal growth factor receptor family Endocr Relat Cancer 12 (Supplement 1) S17-S27, doi:10.1677/erc.1.01032
  12. Original Research:
    • N Angelopoulos,
    • V Barbounis,
    • S Livadas,
    • D Kaltsas,
    • and G Tolis
    Effects of estrogen deprivation due to breast cancer treatment Endocr Relat Cancer 11 (3) 523-535, doi:10.1677/erc.1.00783
  13. Commentary:
    • Kristien Boelaert
    The association between serum TSH concentration and thyroid cancer Endocr Relat Cancer 16 (4) 1065-1072, doi:10.1677/ERC-09-0150 first published on 20 July 2009
  14. Review:
    • Vera Tiedje,
    • Martin Stuschke,
    • Frank Weber,
    • Henning Dralle,
    • Laura Moss,
    • and Dagmar Führer
    Anaplastic thyroid carcinoma: review of treatment protocols Endocr Relat Cancer 25 (3) R153-R161, doi:10.1530/ERC-17-0435 first published on 2 January 2018
  15. Review:
    • Sefirin Djiogue,
    • Armel Hervé Nwabo Kamdje,
    • Lorella Vecchio,
    • Maulilio John Kipanyula,
    • Mohammed Farahna,
    • Yousef Aldebasi,
    • and Paul Faustin Seke Etet
    Insulin resistance and cancer: the role of insulin and IGFs Endocr Relat Cancer 20 (1) R1-R17, doi:10.1530/ERC-12-0324 first published on 3 December 2012
  16. Thematic Review:
    • Frederic Castinetti,
    • Jeffrey Moley,
    • Lois Mulligan,
    • and Steven G Waguespack
    A comprehensive review on MEN2B Endocr Relat Cancer 25 (2) T29-T39, doi:10.1530/ERC-17-0209 first published on 11 July 2017
  17. Thematic Review:
    • Stephan Gasser,
    • Lina H K Lim,
    • and Florence S G Cheung
    The role of the tumour microenvironment in immunotherapy Endocr Relat Cancer 24 (12) T283-T295, doi:10.1530/ERC-17-0146 first published on 28 July 2017
  18. Thematic Review:
    • Lucas Leite Cunha,
    • Marjory Alana Marcello,
    • Vinicius Rocha-Santos,
    • and Laura Sterian Ward
    Immunotherapy against endocrine malignancies: immune checkpoint inhibitors lead the way Endocr Relat Cancer 24 (12) T261-T281, doi:10.1530/ERC-17-0222 first published on 11 September 2017
  19. Review:
    • Andrew M K Law,
    • Elgene Lim,
    • Christopher J Ormandy,
    • and David Gallego-Ortega
    The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy Endocr Relat Cancer 24 (4) R123-R144, doi:10.1530/ERC-16-0404 first published on 13 February 2017
    OPEN ACCESS ARTICLE
  20. Focus Review:
    • Benjamin Boyerinas,
    • Sun-Mi Park,
    • Annika Hau,
    • Andrea E Murmann,
    • and Marcus E Peter
    The role of let-7 in cell differentiation and cancer Endocr Relat Cancer 17 (1) F19-F36, doi:10.1677/ERC-09-0184 first published on 24 September 2009
  21. Review:
    • Alberto Fernandez,
    • Michael Brada,
    • Lina Zabuliene,
    • Niki Karavitaki,
    • and John A H Wass
    Radiation-induced hypopituitarism Endocr Relat Cancer 16 (3) 733-772, doi:10.1677/ERC-08-0231 first published on 4 June 2009
  22. Review:
    • Gregory A Kaltsas,
    • Jane Evanson,
    • Alexandra Chrisoulidou,
    • and Ashley B Grossman
    The diagnosis and management of parasellar tumours of the pituitary Endocr Relat Cancer 15 (4) 885-903, doi:10.1677/ERC-08-0170 first published on 22 September 2008
  23. Focus Review:
    • Dara Hope Cohen and
    • Derek LeRoith
    Obesity, type 2 diabetes, and cancer: the insulin and IGF connection Endocr Relat Cancer 19 (5) F27-F45, doi:10.1530/ERC-11-0374 first published on 16 May 2012
  24. Thematic Review:
    • Sara Redaelli,
    • Ivan Plaza-Menacho,
    • and Luca Mologni
    Novel targeted therapeutics for MEN2 Endocr Relat Cancer 25 (2) T53-T68, doi:10.1530/ERC-17-0297
  25. Reviews:
    • Graeme Eisenhofer,
    • Stefan R Bornstein,
    • Frederieke M Brouwers,
    • Nai-Kong V Cheung,
    • Patricia L Dahia,
    • Ronald R de Krijger,
    • Thomas J Giordano,
    • Lloyd A Greene,
    • David S Goldstein,
    • Hendrik Lehnert,
    • William M Manger,
    • John M Maris,
    • Hartmut P H Neumann,
    • Karel Pacak,
    • Barry L Shulkin,
    • David I Smith,
    • Arthur S Tischler,
    • and William F Young, Jr
    Malignant pheochromocytoma: current status and initiatives for future progress Endocr Relat Cancer 11 (3) 423-436, doi:10.1677/erc.1.00829
  26. Editorial:
    • Serisha Moodley,
    • Frank Weber,
    • and Lois M Mulligan
    The evolving clinical, genetic and therapeutic landscape of multiple endocrine neoplasia type 2 Endocr Relat Cancer 25 (2) E1-E4, doi:10.1530/ERC-17-0488
  27. Review:
    • Callum Livingstone
    IGF2 and cancer Endocr Relat Cancer 20 (6) R321-R339, doi:10.1530/ERC-13-0231 first published on 30 September 2013
  28. Reviews:
    • Marc Lacroix,
    • Robert-Alain Toillon,
    • and Guy Leclercq
    p53 and breast cancer, an update Endocr Relat Cancer 13 (2) 293-325, doi:10.1677/erc.1.01172
  29. Thematic Review:
    • Christine Helsen,
    • Thomas Van den Broeck,
    • Arnout Voet,
    • Stefan Prekovic,
    • Hendrik Van Poppel,
    • Steven Joniau,
    • and Frank Claessens
    Androgen receptor antagonists for prostate cancer therapy Endocr Relat Cancer 21 (4) T105-T118, doi:10.1530/ERC-13-0545 first published on 17 March 2014
  30. Review:
    • Conleth G Murphy and
    • Maura N Dickler
    Endocrine resistance in hormone-responsive breast cancer: mechanisms and therapeutic strategies Endocr Relat Cancer 23 (8) R337-R352, doi:10.1530/ERC-16-0121 first published on 12 July 2016
  31. Review:
    • Fidéline Bonnet-Serrano and
    • Jérôme Bertherat
    Genetics of tumors of the adrenal cortex Endocr Relat Cancer 25 (3) R131-R152, doi:10.1530/ERC-17-0361 first published on 12 December 2017
  32. Reviews:
    • Paul Carter,
    • Leia Smith,
    • and Maureen Ryan
    Identification and validation of cell surface antigens for antibody targeting in oncology Endocr Relat Cancer 11 (4) 659-687, doi:10.1677/erc.1.00766
  33. Review:
    • Philipp Y Maximov,
    • Balkees Abderrahman,
    • Ramona F Curpan,
    • Yousef M Hawsawi,
    • Ping Fan,
    • and V Craig Jordan
    A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers Endocr Relat Cancer 25 (2) R83-R113, doi:10.1530/ERC-17-0416 first published on 21 November 2017
    OPEN ACCESS ARTICLE
  34. Review:
    • David L Vesely
    Cardiac hormones for the treatment of cancer Endocr Relat Cancer 20 (3) R113-R125, doi:10.1530/ERC-13-0054 first published on 26 March 2013
  35. Research:
    • Noriko Kimura,
    • Ryoichi Takayanagi,
    • Nae Takizawa,
    • Eiji Itagaki,
    • Takayuki Katabami,
    • Narihiko Kakoi,
    • Hiromi Rakugi,
    • Yukihiro Ikeda,
    • Akiyo Tanabe,
    • Takeshi Nigawara,
    • Sadayoshi Ito,
    • Itaru Kimura,
    • Mitsuhide Naruse,
    • and The Phaeochromocytoma Study Group in Japan
    Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma Endocr Relat Cancer 21 (3) 405-414, doi:10.1530/ERC-13-0494 first published on 12 February 2014
  36. Review:
    • Carolyn M Klinge
    Noncoding RNAs: long non-coding RNAs and microRNAs in endocrine-related cancers Endocr Relat Cancer ERC-17-0548, doi:10.1530/ERC-17-0548 first published on 12 February 2018
  37. Research:
    • Marianne Pavel,
    • David J Gross,
    • Marta Benavent,
    • Petros Perros,
    • Raj Srirajaskanthan,
    • Richard R P Warner,
    • Matthew H Kulke,
    • Lowell B Anthony,
    • Pamela L Kunz,
    • Dieter Hörsch,
    • Martin O Weickert,
    • Pablo Lapuerta,
    • Wenjun Jiang,
    • Kenneth Kassler-Taub,
    • Suman Wason,
    • Rosanna Fleming,
    • Douglas Fleming,
    • and Rocio Garcia-Carbonero
    Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial Endocr Relat Cancer 25 (3) 309-322, doi:10.1530/ERC-17-0455 first published on 12 January 2018
    OPEN ACCESS ARTICLE
  38. Review:
    • Priya Gopie,
    • Lin Mei,
    • Anthony C Faber,
    • Steven R Grossman,
    • Steven C Smith,
    • and Sosipatros A Boikos
    Classification of gastrointestinal stromal tumor syndromes Endocr Relat Cancer 25 (2) R49-R58, doi:10.1530/ERC-17-0329 first published on 23 November 2017
  39. Reviews:
    • M Niedziela
    Pathogenesis, diagnosis and management of thyroid nodules in children Endocr Relat Cancer 13 (2) 427-453, doi:10.1677/erc.1.00882
  40. Research:
    • Cécile M Vouyovitch,
    • Jo K Perry,
    • Dong Xu Liu,
    • Laurent Bezin,
    • Eric Vilain,
    • Jean-Jacques Diaz,
    • Peter E Lobie,
    • and Hichem C Mertani
    WNT4 mediates the autocrine effects of growth hormone in mammary carcinoma cells Endocr Relat Cancer 23 (7) 571-585, doi:10.1530/ERC-15-0528 first published on 20 June 2016
  41. Research:
    • Tobias Hofving,
    • Yvonne Arvidsson,
    • Bilal Almobarak,
    • Linda Inge,
    • Roswitha Pfragner,
    • Marta Persson,
    • Göran Stenman,
    • Erik Kristiansson,
    • Viktor Johanson,
    • and Ola Nilsson
    The neuroendocrine phenotype, genomic profile and therapeutic sensitivity of GEPNET cell lines Endocr Relat Cancer 25 (3) 367-380, doi:10.1530/ERC-17-0445
    OPEN ACCESS ARTICLE
  42. Thematic Review:
    • Rami Alrezk,
    • Fady Hannah-Shmouni,
    • and Constantine A Stratakis
    MEN4 and CDKN1B mutations: the latest of the MEN syndromes Endocr Relat Cancer 24 (10) T195-T208, doi:10.1530/ERC-17-0243 first published on 19 August 2017
  43. Thematic Review:
    • Rachel S van Leeuwaarde,
    • Joanne M de Laat,
    • Carolina R C Pieterman,
    • Koen Dreijerink,
    • Menno R Vriens,
    • and Gerlof D Valk
    The future: medical advances in MEN1 therapeutic approaches and management strategies Endocr Relat Cancer 24 (10) T179-T193, doi:10.1530/ERC-17-0225 first published on 2 August 2017
  44. Review:
    • Antonio De la Vieja and
    • Pilar Santisteban
    Role of iodide metabolism in physiology and cancer Endocr Relat Cancer 25 (4) R225-R245, doi:10.1530/ERC-17-0515 first published on 1 February 2018
  45. Review:
    • Lars C Moeller and
    • Dagmar Führer
    Thyroid hormone, thyroid hormone receptors, and cancer: a clinical perspective Endocr Relat Cancer 20 (2) R19-R29, doi:10.1530/ERC-12-0219 first published on 14 January 2013
  46. Thematic Review:
    • Keely M McNamara,
    • Nicole L Moore,
    • Theresa E Hickey,
    • Hironobu Sasano,
    • and Wayne D Tilley
    Complexities of androgen receptor signalling in breast cancer Endocr Relat Cancer 21 (4) T161-T181, doi:10.1530/ERC-14-0243 first published on 20 June 2014
  47. Thematic Review:
    • Samuel A Wells, Jr
    Advances in the management of MEN2: from improved surgical and medical treatment to novel kinase inhibitors Endocr Relat Cancer 25 (2) T1-T13, doi:10.1530/ERC-17-0325 first published on 15 November 2017
  48. Reviews:
    • P M Harari
    Epidermal growth factor receptor inhibition strategies in oncology Endocr Relat Cancer 11 (4) 689-708, doi:10.1677/erc.1.00600
  49. Research:
    • Patrick Petrossians,
    • Adrian F Daly,
    • Emil Natchev,
    • Luigi Maione,
    • Karin Blijdorp,
    • Mona Sahnoun-Fathallah,
    • Renata Auriemma,
    • Alpha M Diallo,
    • Anna-Lena Hulting,
    • Diego Ferone,
    • Vaclav Hana, Jr,
    • Silvia Filipponi,
    • Caroline Sievers,
    • Claudia Nogueira,
    • Carmen Fajardo-Montañana,
    • Davide Carvalho,
    • Vaclav Hana,
    • Günter K Stalla,
    • Marie-Lise Jaffrain-Réa,
    • Brigitte Delemer,
    • Annamaria Colao,
    • Thierry Brue,
    • Sebastian J C M M Neggers,
    • Sabina Zacharieva,
    • Philippe Chanson,
    • and Albert Beckers
    Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database Endocr Relat Cancer 24 (10) 505-518, doi:10.1530/ERC-17-0253 first published on 21 July 2017
    OPEN ACCESS ARTICLE
  50. Review:
    • David Viola,
    • Laura Valerio,
    • Eleonora Molinaro,
    • Laura Agate,
    • Valeria Bottici,
    • Agnese Biagini,
    • Loredana Lorusso,
    • Virginia Cappagli,
    • Letizia Pieruzzi,
    • Carlotta Giani,
    • Elena Sabini,
    • Paolo Passannati,
    • Luciana Puleo,
    • Antonio Matrone,
    • Benedetta Pontillo-Contillo,
    • Valentina Battaglia,
    • Salvatore Mazzeo,
    • Paolo Vitti,
    • and Rossella Elisei
    Treatment of advanced thyroid cancer with targeted therapies: ten years of experience Endocr Relat Cancer 23 (4) R185-R205, doi:10.1530/ERC-15-0555
  51. Thematic Review:
    • Roberta Visconti and
    • Domenico Grieco
    Fighting tubulin-targeting anticancer drug toxicity and resistance Endocr Relat Cancer 24 (9) T107-T117, doi:10.1530/ERC-17-0120
  52. Thematic Review:
    • Rachana Rao Battaje and
    • Dulal Panda
    Lessons from bacterial homolog of tubulin, FtsZ for microtubule dynamics Endocr Relat Cancer 24 (9) T1-T21, doi:10.1530/ERC-17-0118 first published on 20 June 2017
  53. Review:
    • Catherine Zabkiewicz,
    • Jeyna Resaul,
    • Rachel Hargest,
    • Wen Guo Jiang,
    • and Lin Ye
    Bone morphogenetic proteins, breast cancer, and bone metastases: striking the right balance Endocr Relat Cancer 24 (10) R349-R366, doi:10.1530/ERC-17-0139 first published on 21 July 2017
    OPEN ACCESS ARTICLE
  54. Reviews:
    • Ioannis Ilias,
    • Anju Sahdev,
    • Rodney H Reznek,
    • Ashley B Grossman,
    • and Karel Pacak
    The optimal imaging of adrenal tumours: a comparison of different methods Endocr Relat Cancer 14 (3) 587-599, doi:10.1677/ERC-07-0045
  55. Thematic Review:
    • Alexander J Cole,
    • Roderick Clifton-Bligh,
    • and Deborah J Marsh
    Histone H2B monoubiquitination: roles to play in human malignancy Endocr Relat Cancer 22 (1) T19-T33, doi:10.1530/ERC-14-0185 first published on 2 June 2014
  56. Thematic Review:
    • Amulya Sreekumar,
    • Kevin Roarty,
    • and Jeffrey M Rosen
    The mammary stem cell hierarchy: a looking glass into heterogeneous breast cancer landscapes Endocr Relat Cancer 22 (6) T161-T176, doi:10.1530/ERC-15-0263 first published on 23 July 2015
  57. Thematic Review:
    • Sunita K Agarwal
    The future: genetics advances in MEN1 therapeutic approaches and management strategies Endocr Relat Cancer 24 (10) T119-T134, doi:10.1530/ERC-17-0199
  58. Review:
    • Jan Willem B de Groot,
    • Bart Rikhof,
    • Jaap van Doorn,
    • Henk J G Bilo,
    • Maarten A Alleman,
    • Aafke H Honkoop,
    • and Winette T A van der Graaf
    Non-islet cell tumour-induced hypoglycaemia: a review of the literature including two new cases Endocr Relat Cancer 14 (4) 979-993, doi:10.1677/ERC-07-0161
  59. Review:
    • Sergio Vargas-Salas,
    • José R Martínez,
    • Soledad Urra,
    • José Miguel Domínguez,
    • Natalia Mena,
    • Thomas Uslar,
    • Marcela Lagos,
    • Marcela Henríquez,
    • and Hernán E González
    Genetic testing for indeterminate thyroid cytology: review and meta-analysis Endocr Relat Cancer 25 (3) R163-R177, doi:10.1530/ERC-17-0405 first published on 18 December 2017
    OPEN ACCESS ARTICLE
  60. Review:
    • Natalie Sampson,
    • Hannes Neuwirt,
    • Martin Puhr,
    • Helmut Klocker,
    • and Iris E Eder
    In vitro model systems to study androgen receptor signaling in prostate cancer Endocr Relat Cancer 20 (2) R49-R64, doi:10.1530/ERC-12-0401 first published on 27 February 2013
  61. Thematic Review:
    • Roger L Milne and
    • Antonis C Antoniou
    Modifiers of breast and ovarian cancer risks for BRCA1 and BRCA2 mutation carriers Endocr Relat Cancer 23 (10) T69-T84, doi:10.1530/ERC-16-0277 first published on 15 August 2016
  62. Review:
    • Michael Solarski,
    • Fabio Rotondo,
    • William D Foulkes,
    • John R Priest,
    • Luis V Syro,
    • Henriett Butz,
    • Michael D Cusimano,
    • and Kalman Kovacs
    DICER1 gene mutations in endocrine tumors Endocr Relat Cancer 25 (3) R197-R208, doi:10.1530/ERC-17-0509 first published on 12 January 2018
  63. Review:
    • Hong-Jun Song,
    • Yan-Li Xue,
    • Yan-Hong Xu,
    • Zhong-Ling Qiu,
    • and Quan-Yong Luo
    Rare metastases of differentiated thyroid carcinoma: pictorial review Endocr Relat Cancer 18 (5) R165-R174, doi:10.1530/ERC-11-0068 first published on 1 June 2011
  64. Review:
    • Krystallenia I Alexandraki,
    • Gregory A Kaltsas,
    • Simona Grozinsky-Glasberg,
    • Eleftherios Chatzellis,
    • and Ashley B Grossman
    Appendiceal neuroendocrine neoplasms: diagnosis and management Endocr Relat Cancer 23 (1) R27-R41, doi:10.1530/ERC-15-0310 first published on 19 October 2015
  65. Review:
    • Clovis Boibessot and
    • Paul Toren
    Sex steroids in the tumor microenvironment and prostate cancer progression Endocr Relat Cancer 25 (3) R179-R196, doi:10.1530/ERC-17-0493 first published on 9 January 2018
  66. Review:
    • Fadi Nabhan and
    • Matthew D Ringel
    Thyroid nodules and cancer management guidelines: comparisons and controversies Endocr Relat Cancer 24 (2) R13-R26, doi:10.1530/ERC-16-0432 first published on 13 December 2016
  67. Regular papers:
    • Natacha Driessens,
    • Soetkin Versteyhe,
    • Chiraz Ghaddhab,
    • Agnès Burniat,
    • Xavier De Deken,
    • Jacqueline Van Sande,
    • Jacques-Emile Dumont,
    • Françoise Miot,
    • and Bernard Corvilain
    Hydrogen peroxide induces DNA single- and double-strand breaks in thyroid cells and is therefore a potential mutagen for this organ Endocr Relat Cancer 16 (3) 845-856, doi:10.1677/ERC-09-0020 first published on 9 June 2009
  68. Thematic Review:
    • Arthur S Tischler and
    • Ronald R deKrijger
    15 YEARS OF PARAGANGLIOMA: Pathology of pheochromocytoma and paraganglioma Endocr Relat Cancer 22 (4) T123-T133, doi:10.1530/ERC-15-0261 first published on 1 July 2015
  69. Reviews:
    • Eduardo Vilar,
    • Ramón Salazar,
    • Jose Pérez-García,
    • Javier Cortes,
    • Kjell Öberg,
    • and Josep Tabernero
    Chemotherapy and role of the proliferation marker Ki-67 in digestive neuroendocrine tumors Endocr Relat Cancer 14 (2) 221-232, doi:10.1677/ERC-06-0074
  70. Thematic Review:
    • Iván Plaza-Menacho
    Structure and function of RET in multiple endocrine neoplasia type 2 Endocr Relat Cancer 25 (2) T79-T90, doi:10.1530/ERC-17-0354 first published on 24 November 2017
  71. Review:
    • Jenny Welander,
    • Peter Söderkvist,
    • and Oliver Gimm
    Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas Endocr Relat Cancer 18 (6) R253-R276, doi:10.1530/ERC-11-0170 first published on 31 October 2011
  72. Review:
    • Lindsay G Carter,
    • John A D'Orazio,
    • and Kevin J Pearson
    Resveratrol and cancer: focus on in vivo evidence Endocr Relat Cancer 21 (3) R209-R225, doi:10.1530/ERC-13-0171 first published on 5 February 2014
    OPEN ACCESS ARTICLE
  73. Regular papers:
    • Wiebke Fenske,
    • Hans-Ullrich Völker,
    • Patrick Adam,
    • Stefanie Hahner,
    • Sarah Johanssen,
    • Sebastian Wortmann,
    • Melanie Schmidt,
    • Michael Morcos,
    • Hans-Konrad Müller-Hermelink,
    • Bruno Allolio,
    • and Martin Fassnacht
    Glucose transporter GLUT1 expression is an stage-independent predictor of clinical outcome in adrenocortical carcinoma Endocr Relat Cancer 16 (3) 919-928, doi:10.1677/ERC-08-0211 first published on 23 May 2009
  74. Review:
    • Amandine Berdelou,
    • Livia Lamartina,
    • Michele Klain,
    • Sophie Leboulleux,
    • Martin Schlumberger,
    • and on behalf of the TUTHTYREF Network
    • , on behalf of the TUTHTYREF Network
    Treatment of refractory thyroid cancer Endocr Relat Cancer 25 (4) R209-R223, doi:10.1530/ERC-17-0542 first published on 25 January 2018
  75. Review:
    • Georgios K Dimitriadis,
    • Anna Angelousi,
    • Martin O Weickert,
    • Harpal S Randeva,
    • Gregory Kaltsas,
    • and Ashley Grossman
    Paraneoplastic endocrine syndromes Endocr Relat Cancer 24 (6) R173-R190, doi:10.1530/ERC-17-0036 first published on 24 March 2017
  76. Review:
    • Lisa M Butler,
    • Margaret M Centenera,
    • and Johannes V Swinnen
    Androgen control of lipid metabolism in prostate cancer: novel insights and future applications Endocr Relat Cancer 23 (5) R219-R227, doi:10.1530/ERC-15-0556 first published on 29 April 2016
  77. Reviews:
    • Rossella Libè,
    • Amato Fratticci,
    • and Jérôme Bertherat
    Adrenocortical cancer: pathophysiology and clinical management Endocr Relat Cancer 14 (1) 13-28, doi:10.1677/erc.1.01130
  78. Commentary:
    • S L Asa,
    • O Casar-Borota,
    • P Chanson,
    • E Delgrange,
    • P Earls,
    • S Ezzat,
    • A Grossman,
    • H Ikeda,
    • N Inoshita,
    • N Karavitaki,
    • M Korbonits,
    • E R Laws, Jr,
    • M B Lopes,
    • N Maartens,
    • I E McCutcheon,
    • O Mete,
    • H Nishioka,
    • G Raverot,
    • F Roncaroli,
    • W Saeger,
    • L V Syro,
    • A Vasiljevic,
    • C Villa,
    • A Wierinckx,
    • J Trouillas,
    • and and the attendees of 14th Meeting of the International Pituitary Pathology Club, Annecy, France, November 2016
    From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal Endocr Relat Cancer 24 (4) C5-C8, doi:10.1530/ERC-17-0004
  79. Reviews:
    • M Xing
    BRAF mutation in thyroid cancer Endocr Relat Cancer 12 (2) 245-262, doi:10.1677/erc.1.0978
  80. Thematic Review:
    • Joanna Grey and
    • Kym Winter
    Patient quality of life and prognosis in multiple endocrine neoplasia type 2 Endocr Relat Cancer 25 (2) T69-T77, doi:10.1530/ERC-17-0335 first published on 24 October 2017
  81. Reviews:
    • G S Harrison,
    • M E Wierman,
    • T M Nett,
    • and L M Glode
    Gonadotropin-releasing hormone and its receptor in normal and malignant cells Endocr Relat Cancer 11 (4) 725-748, doi:10.1677/erc.1.00777
  82. Review:
    • Kjell Öberg and
    • Steven W J Lamberts
    Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future Endocr Relat Cancer 23 (12) R551-R566, doi:10.1530/ERC-16-0151 first published on 3 October 2016
  83. Research:
    • Soomin Ahn,
    • Tae Hyuk Kim,
    • Sun Wook Kim,
    • Chang Seok Ki,
    • Hye Won Jang,
    • Jee Soo Kim,
    • Jung Han Kim,
    • Jun-Ho Choe,
    • Jung Hee Shin,
    • Soo Yeon Hahn,
    • Young Lyun Oh,
    • and Jae Hoon Chung
    Comprehensive screening for PD-L1 expression in thyroid cancer Endocr Relat Cancer 24 (2) 97-106, doi:10.1530/ERC-16-0421
  84. Thematic Review:
    • Carole Guerin,
    • Pauline Romanet,
    • David Taieb,
    • Thierry Brue,
    • André Lacroix,
    • Frederic Sebag,
    • Anne Barlier,
    • and Frederic Castinetti
    Looking beyond the thyroid: advances in the understanding of pheochromocytoma and hyperparathyroidism phenotypes in MEN2 and of non-MEN2 familial forms Endocr Relat Cancer 25 (2) T15-T28, doi:10.1530/ERC-17-0266 first published on 5 September 2017
  85. Thematic Review:
    • Michael Derwahl and
    • Diana Nicula
    Estrogen and its role in thyroid cancer Endocr Relat Cancer 21 (5) T273-T283, doi:10.1530/ERC-14-0053 first published on 22 July 2014
  86. Review:
    • Rhonda L Bitting and
    • Andrew J Armstrong
    Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer Endocr Relat Cancer 20 (3) R83-R99, doi:10.1530/ERC-12-0394 first published on 1 March 2013
  87. Reviews:
    • A M Lorincz and
    • S Sukumar
    Molecular links between obesity and breast cancer Endocr Relat Cancer 13 (2) 279-292, doi:10.1677/erc.1.00729
  88. Reviews:
    • Alistair Ring and
    • Mitch Dowsett
    Mechanisms of tamoxifen resistance Endocr Relat Cancer 11 (4) 643-658, doi:10.1677/erc.1.00776
  89. Editorial:
    • Frank Weber and
    • Lois M Mulligan
    Happy 20th anniversary MEN1: from positional cloning to gene function restoration Endocr Relat Cancer 24 (10) E7-E11, doi:10.1530/ERC-17-0346
  90. Research:
    • Matthias S Dettmer,
    • Anja Schmitt,
    • Hans Steinert,
    • David Capper,
    • Holger Moch,
    • Paul Komminoth,
    • and Aurel Perren
    Tall cell papillary thyroid carcinoma: new diagnostic criteria and mutations in BRAF and TERT Endocr Relat Cancer 22 (3) 419-429, doi:10.1530/ERC-15-0057 first published on 13 April 2015
  91. Supplement Paper:
    • Günter Klöppel
    Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms Endocr Relat Cancer 18 (S1) S1-S16, doi:10.1530/ERC-11-0013
  92. Thematic Review:
    • Amélie Fradet-Turcotte,
    • Justine Sitz,
    • Damien Grapton,
    • and Alexandre Orthwein
    BRCA2 functions: from DNA repair to replication fork stabilization Endocr Relat Cancer 23 (10) T1-T17, doi:10.1530/ERC-16-0297 first published on 16 August 2016
  93. Review:
    • Gregory Kaltsas,
    • Ioannis I Androulakis,
    • Wouter W de Herder,
    • and Ashley B Grossman
    Paraneoplastic syndromes secondary to neuroendocrine tumours Endocr Relat Cancer 17 (3) R173-R193, doi:10.1677/ERC-10-0024 first published on 8 June 2010
  94. Reviews:
    • G Olt and
    • R Mortel
    Hormone-producing tumors of the ovary Endocr Relat Cancer 4 (4) 447-457, doi:10.1677/erc.0.0040447
  95. Review:
    • M Fraenkel,
    • M Kim,
    • A Faggiano,
    • W W de Herder,
    • G D Valk,
    • and On behalf of the Knowledge NETwork
    Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature Endocr Relat Cancer 21 (3) R153-R163, doi:10.1530/ERC-13-0125 first published on 9 December 2013
  96. Research:
    • Samah Rafehi,
    • Yudith Ramos Valdes,
    • Monique Bertrand,
    • Jacob McGee,
    • Michel Préfontaine,
    • Akira Sugimoto,
    • Gabriel E DiMattia,
    • and Trevor G Shepherd
    TGFβ signaling regulates epithelial–mesenchymal plasticity in ovarian cancer ascites-derived spheroids Endocr Relat Cancer 23 (3) 147-159, doi:10.1530/ERC-15-0383 first published on 8 December 2015
  97. Thematic Review:
    • Frédéric Castinetti,
    • Alexander Kroiss,
    • Rakesh Kumar,
    • Karel Pacak,
    • and David Taieb
    15 YEARS OF PARAGANGLIOMA: Imaging and imaging-based treatment of pheochromocytoma and paraganglioma Endocr Relat Cancer 22 (4) T135-T145, doi:10.1530/ERC-15-0175 first published on 4 June 2015
    • N Prenzel,
    • O M Fischer,
    • S Streit,
    • S Hart,
    • and A Ullrich
    The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification. Endocr Relat Cancer 8 (1) 11-31, doi:10.1677/erc.0.0080011
  99. Review:
    • Annunziata Di Domenico,
    • Tabea Wiedmer,
    • Ilaria Marinoni,
    • and Aurel Perren
    Genetic and epigenetic drivers of neuroendocrine tumours (NET) Endocr Relat Cancer 24 (9) R315-R334, doi:10.1530/ERC-17-0012 first published on 14 July 2017
  100. Thematic Review:
    • Zijie Feng,
    • Jian Ma,
    • and Xianxin Hua
    Epigenetic regulation by the menin pathway Endocr Relat Cancer 24 (10) T147-T159, doi:10.1530/ERC-17-0298 first published on 15 August 2017

Last updated 03/02/2018 19:00:50

New Articles: issue in progress

  1. May 2018, 25 (5)
  1. Current Issue
  1. Alert me to new issues of Endocrine-Related Cancer

Most